Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.

In this prospective, double-sided patient-controlled therapeutical trial involving 20 patients with alopecia areata, we investigated the efficacy of topical acid dibutylester (SADBE) in the treatment of alopecia areata. Sensitisation was achieved with 2% SADBE in acetone followed by weekly application of topical SADBE to designated alopecia sites for 20 weeks. Untreated alopecia sites on the same patient acted as controls. Nineteen of the twenty patients completed 20 weeks of treatment. On the SADBE treated sites, excellent response (> 75% hair regrowth) was observed in 68% (13/19) of patients at the end of 20 weeks of treatment. On the untreated control sites, the corresponding figure was 11% (2/19). The difference in response between SADBE treated and untreated sites was statistically significant (P < 0.001). Mean onset of hair regrowth was 6 weeks after starting treatment. Patients with duration of alopecia 12 months or longer fared poorer compared with patients with a shorter duration of the disease. The extent of involvement did not appear to influence treatment outcome. Side effects were mainly local and were mainly local and were well tolerated. At 6 months follow-up, 33% (2/6) of responders with alopecia totalis relapsed compared to 11% (19) of those with patchy alopecia areata. We conclude that topical immunotherapy with SADBE is effective in inducing hair regrowth in alopecia areata.
AuthorsS H Chua, C L Goh, C B Ang
JournalAnnals of the Academy of Medicine, Singapore (Ann Acad Med Singapore) Vol. 25 Issue 6 Pg. 842-7 (Nov 1996) ISSN: 0304-4602 [Print] SINGAPORE
PMID9055014 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Allergens
  • Cyclobutanes
  • squaric acid dibutyl ester
  • Administration, Topical
  • Adolescent
  • Adult
  • Allergens (administration & dosage, adverse effects)
  • Alopecia Areata (diagnosis, drug therapy, physiopathology)
  • Cyclobutanes (administration & dosage, adverse effects)
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Hair (drug effects, growth & development)
  • Humans
  • Immunotherapy
  • Male
  • Middle Aged
  • Prospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: